Molecular Assemblies

The life science industry is driven in large part by our growing understanding of the genome. Taking the industry to the next level requires equal advances in synthesizing DNA or “writing’ new genomes. Cost-effective, high-quality methods for writing this genetic code will enable programming of cells to produce new sources of advanced therapeutics, food, fuels, advanced chemicals, agricultural products and eventually big data storage, nanomachines and bioelectronics. Two of the founding members of ABI, the original genomics tools company, have reunited to develop a patented enzymatic process to advance writing of these important genomes.